%0 Journal Article
%T Hematologic Abnormalities in Treatment-Na ve HIV Patients
%A Akinsegun Akinbami
%A Olajumoke Oshinaike
%A Titilope Adeyemo
%A Adewunmi Adediran
%A Owolabi Dosunmu
%A Mobolaji Dada
%A Idris Durojaiye
%A Alaba Adebola and Oshunkalu Vincent
%J Infectious Diseases: Research and Treatment
%D 2012
%I 
%R 10.4137/IDRT.S6033
%X Objectives: Hematologic abnormalities, indicated by a deranged full blood count, are common manifestations and important prognostic tools for human immunodeficiency virus (HIV) infection and AIDS. This study aimed to determine the prevalence of cytopenia and its relationship to the degree of immunosupression in HIV treatment-na ve patients. Methods: This was a cross-sectional study of treatment-na ve HIV-infected clients who enrolled at the HIV clinic of Lagos State University Teaching Hospital (LASUTH) between December 2009 and June 2010. Participants had samples taken for full blood count and CD4 counts, which are free routine pre-requisite and pre-treatment evaluations done for all registered HIV patients at LASUTH. They were asked to fill the structured questionnaires to obtain demographic data, with assistance if necessary. Results: A total of 205 cases were reviewed: 24.2% had anemia (PCV < 30%), 26.8% had leucopenia (white blood cell <4,000/L) and 16.1% had thrombocytopenia (platelet count <150,000/L) at enrollment. The degree of cytopenia was directly related to the degree of immunosupression. Conclusion: About one-fifth of HIV treatment-na ve patients were cytopenic at enrollment and the degree of cytopenia was directly related to the degree of immunosupression. It is necessary to investigate various causes of cytopenia in these patients so as to administer a specific intervention.
%U http://www.la-press.com/hematologic-abnormalities-in-treatment-nave-hiv-patients-article-a2407